From: Patient-reported outcomes associated with cancer screening: a systematic review
 | Study Design | Screening | Measure†| Result | Screening | 2 mo | 3 mo | 4 mo | 5 mo | 6 mo | 7 mo–11 mo | 12 mo | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Within 1 mo | ||||||||||||
Mean (SD) | Mean (SD) | Mean (SD) | |||||||||||
Ruberg et al 2016 [47] N = 180 (Total) N = 16 (Abnormal) • Age: 30–60 years • Women living in Netherlands | Prospective longitudinal | TVS/CA125 | IES-intrusive | Total (Abnormal, Normal) | 3.5 (5.6) | 3.1 (5.0) | 2.4 (4.8) |  |  |  |  |  |  |
Abnormal | 2.9 (4.4) | 3.7 (4.7) | 6.3 (6.4) | Â | Â | Â | Â | Â | Â | ||||
Normal | 3.6 (5.7) | 3.0 (5.1) | 2.1 (4.4)*,a | Â | Â | Â | Â | Â | Â | ||||
van den Bergh et al 2011 [48] N = 600–658 • Age: 50–75 years • NELSON study participants | RCT | LDCT | IES (total) | Indeterminate | 4.0 (2.8–5.3) |  | 7.8 (6.5–9.0)*b |  |  |  |  |  |  |
(−) | 4.1 (3.4–4.8) |  | 2.6 (2.0–3.3) |  |  |  |  |  |  | ||||
IES-intrusive | Indeterminate | 1.9 (1.3–2.4) |  | 3.4 (2.8–3.9) |  |  |  |  |  |  | |||
(−) | 1.7 (1.4–2.0) |  | 1.0 (0.7–1.3) |  |  |  |  |  |  | ||||
IES-avoidance | Indeterminate | 2.2 (1.4–3.0) |  | 4.4 (3.6–5.2) |  |  |  |  |  |  | |||
(−) | 2.3 (1.9–2.8) |  | 1.7 (1.2–2.1) |  |  |  |  |  |  | ||||
van den Bergh et al 2010 [41] N = 600–641 • Age: 50–75 years • NELSON study participants | RCT | LDCT | IES (total) | Indeterminate | 4.5 (6.5) | 4.9 (8.4) | 8.3 (11.3)*,c |  |  |  |  |  |  |
(−) | 4.1 (7.4) | 4.5 (7.7) | 2.4 (5.5)*d |  |  |  |  |  |  | ||||
IES-intrusive | Indeterminate | 2.0 (3.0) | 2.0 (3.8) | 3.5 (5.2) | Â | Â | Â | Â | Â | Â | |||
(−) | 1.7 (3.5) | 1.8 (3.5) | 0.8 (2.4) |  |  |  |  |  |  | ||||
IES-avoidance | Indeterminate | 2.5 (4.1) | 2.9 (4.9) | 4.8 (6.9)*c | Â | Â | Â | Â | Â | Â | |||
(−) | 2.4 (3.7) | 2.7 (4.7) | 1.5 (3.7) |  |  |  |  |  |  | ||||
van den Bergh et al 2008 [43] N = 288–324 • Age: 50–75 years • NELSON study participants | RCT | LDCT | IES (total) | Total (−/Incidental) | 3.0e | 1.0e |  |  |  |  |  |  | 2.0e |
IES-intrusive | 1.0e | 0.0e | Â | Â | Â | Â | Â | Â | 0.0e | ||||
IES-avoidance | 1.0e | 0.0e | Â | Â | Â | Â | Â | Â | 1.0e | ||||
Bunge et al 2008 [49] N = 40–47 (High AR) N = 236–247 (Low AR) • Age: 50–75 years • NELSON study participants | RCT | LDCT | IES (total) | High AR | 11.5e |  |  |  |  |  | 6.5e,f,* |  |  |
Low AR | 2.0e | Â | Â | Â | Â | Â | 1.0e,* | Â | Â | ||||
IES-intrusive | High AR | 5.0e | Â | Â | Â | Â | Â | 3.5e,* | Â | Â | |||
Low AR | 1.0e | Â | Â | Â | Â | Â | 0.0e,* | Â | Â | ||||
IES-avoidance | High AR | 5.0e | Â | Â | Â | Â | Â | 3.0e,* | Â | Â | |||
Low AR | 1.0e | Â | Â | Â | Â | Â | 0.5e,* | Â | Â |